Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access |
Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc |
Journal website https://www.journalmc.org |
Case Report
Volume 12, Number 12, December 2021, pages 474-480
Successful Treatment of Thrombocytopenia, Anasarca, Fever, Reticulin Myelofibrosis/Renal Insufficiency, and Organomegaly Syndrome Using Plasma Exchange Followed by Rituximab in the Intensive Care Unit
Figures
Table
General ward | ICU | ||||||
---|---|---|---|---|---|---|---|
On admission (day 1) | On diagnosis (day 17) | On ICU admission (day 24) | Before PE (day 25) | After PE (day 33) | Before rituximab (day 34) | After rituximab (day 42) | |
Bone marrow biopsy; M-protein (-). ICU: intensive care unit; PE: plasma exchange; WBC: white blood cell; RBC: red blood cell; AST: aspartate aminotransferase; ALT: alanine aminotransferase; LDH: lactate dehydrogenase; ALP: alkaline phosphatase; γ-GTP: γ-glutamyltranspeptidase; BUN: blood urea nitrogen; CRP: C-reactive protein; ANA: antinuclear antibody; IgG: Immunoglobulin G; IgM: Immunoglobulin M; IgA: Immunoglobulin A; sIL-2R: soluble interleukin-2 receptor; IL-6: Interleukin-6; VEGF: vascular endothelial growth factor; CMV: cytomegalovirus; EBV VCA: Epstein-Barr virus virus capsid antigen; HIV: human immunodeficiency virus. | |||||||
WBC (× 103/µL) | 6.2 | 14.6 | 14.6 | 20.2 | 25 | 15.5 | 5.9 |
RBC (× 106/µL) | 4.49 | 3.79 | 2.99 | 3.71 | 3.33 | 3.1 | 3.1 |
Hemoglobin (g/dL) | 13.5 | 10.7 | 11.2 | 10.4 | 10.1 | 9.4 | 9.9 |
Hematocrit (%) | 39.8 | 32.7 | 33.6 | 31.8 | 33 | 29.8 | 31.3 |
Platelet (× 103/µL) | 87 | 15 | 39 | 43 | 52 | 65 | 69 |
Total protein (g/dL) | 6.7 | 4.8 | 5.4 | 5.6 | 5.6 | 5.5 | 5.6 |
Albumin (g/dL) | 3.2 | 1.6 | 1.6 | 1.6 | 2.9 | 2.9 | 2.5 |
AST (U/L) | 40 | 128 | 126 | 117 | 34 | 28 | 25 |
ALT (U/L) | 28 | 33 | 61 | 58 | 22 | 25 | 31 |
LDH (U/L) | 255 | 271 | 250 | 276 | 179 | 199 | 199 |
ALP (U/L) | 258 | 382 | 342 | 340 | 342 | 241 | |
γ-GTP (U/L) | 39 | 31 | 38 | 36 | 35 | 60 | |
Total bilirubin (mg/dL) | 5.1 | 4.4 | 3 | 2.5 | 2.9 | 3.4 | 1.7 |
BUN (mg/dL) | 30 | 65 | 126 | 107 | 74 | 107 | 78 |
Creatinine (mg/dL) | 1.55 | 1.69 | 2.65 | 2.49 | 1.5 | 2.1 | 1.54 |
CRP (mg/dL) | 16.75 | 18.16 | 17.17 | 15.35 | 0.26 | 0.31 | 0.18 |
Ferritin (ng/mL) | 429.5 | ||||||
ANA (speckled) | 160 | ||||||
IgG (mg/dL) | 1,560 | ||||||
IgA (mg/dL) | 384 | ||||||
IgM (mg/dL) | 71 | ||||||
sIL-2R (U/mL) | 761 | ||||||
IL-6 (pg/mL) | 38 | ||||||
VEGF (pg/mL) | 219 | ||||||
CMV IgM | (-) | ||||||
EBV VCA-IgM | (-) | ||||||
HIV | (-) |